Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HYPERION THERAPEUTICS INC (HPTX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Nov-01-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K/A | S-1/A | 10-K/A |
| Revenues | 100.0% | 100.0% | 100.0% | | 100.0% | | | |
| Cost of goods sold | 12.1% | 16.0% | 0.0% | | 0.0% | | | |
| Gross profit | 87.9% | 84.0% | 100.0% | | 100.0% | | | |
| Selling, general and administrative | 42.7% | 84.9% | 39.8% | | 33.6% | | | |
| Research and development | 18.2% | 23.7% | 59.1% | | 64.9% | | | |
| General and administrative | | | | | | | | |
| EBITDA | 27.4% | -24.1% | -98.9% | | -98.2% | | | |
| Depreciation | 0.4% | 0.5% | 0.1% | | 0.3% | | | |
| EBITA | 27.0% | -24.5% | -99.0% | | -98.5% | | | |
| Amortization of intangibles | 4.1% | 7.2% | | | | | | |
| EBIT | 22.9% | -31.8% | -99.0% | | -98.5% | | | |
| Pre-tax income | -5.2% | 39.5% | -111.9% | | -110.8% | | | |
| Income taxes | 0.3% | 0.1% | 0.0% | | 0.0% | | | |
| Net income | -5.5% | 39.4% | -111.9% | | -110.8% | | | |
|